Activation of TLRs usually induces recruitment of the adapter molecule myeloid differentiation primary response protein 88 (MyD88), and activation of TLR/MyD88 typically leads to the activation of NF-κB, which has been linked to the progression of tumours [18]. Here, MYD88 is linked to neoplasm.